556
The case is presented of a 72-year-old man with hormone-refractory prostate cancer and weekly administration of 30 mg/m2 docetaxel who developed subacute interstitial pneumonitis-related pulmonary fibrosis after seven doses and died despite mechanical ventilation and high-dose corticosteroid treatment.
 ( adverse event: developed ,  a 72-year-old man with hormone-refractory prostate cancer: Subject, 72-year-old: Subject.Age, man: Subject.Gender, subacute interstitial pneumonitis-related pulmonary fibrosis: Effect, and died: Effect, weekly administration of 30 mg/m2 docetaxel: Treatment, seven doses: Treatment, despite mechanical ventilation and high-dose corticosteroid treatment: Treatment, weekly: Treatment.Freq, administration: Treatment.Route, 30 mg/m2: Treatment.Dosage, seven doses: Treatment.Dosage, high-dose: Treatment.Dosage, docetaxel: Treatment.Drug, corticosteroid: Treatment.Drug, hormone-refractory prostate cancer: Treatment.Disorder) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  a 72-year-old man with hormone-refractory prostate cancer: Subject, 72-year-old: Subject.Age, man: Subject.Gender, subacute interstitial pneumonitis-related pulmonary fibrosis: Effect, and died: Effect, weekly administration of 30 mg/m2 docetaxel: Treatment, seven doses: Treatment, despite mechanical ventilation and high-dose corticosteroid treatment: Treatment, weekly: Treatment.Freq, administration: Treatment.Route, 30 mg/m2: Treatment.Dosage, seven doses: Treatment.Dosage, high-dose: Treatment.Dosage, docetaxel: Treatment.Drug, corticosteroid: Treatment.Drug, hormone-refractory prostate cancer: Treatment.Disorder) 